Toxopathological Studies on Some Antimicrobial Drugs in Nile Tilapia (Oreochromis Niloticus) and Catfish (Clarias Gariepinus)
Salah Aly M1*, Abdou Rania H2, Nashwa Abdel Atti M3, Mosleh Abomughaid M4 and Wael Nouh G4
1Department of Pathology, Faculty of Veterinary Medicine, Suez Canal University, Egypt
2 Department of Forensic Medicine & Toxicology, Faculty of Veterinary Medicine, Suez Canal University, Egypt
3Animal Health Research Institute, Ismailia Lab, Egypt
4 Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, Saudi Arabia
Submission:April 14, 2020; Published: May 18, 2020
*Corresponding author: Salah Aly M, Department of Pathology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
How to cite this article: Salah A M, Abdou R H, Nashwa A A M, Mosleh A M, Wael N G. Toxopathological Studies on Some Antimicrobial Drugs in Nile Tilapia (Oreochromis Niloticus) and Catfish (Clarias Gariepinus). Open Acc J of Toxicol. 2020; 4(2):555635. DOI: 10.19080/OAJT.2020.04.555635.
Abstract
Tissue distribution, residue depletion and side effect of Ciprofloxacine (CIP), Oxytetracycline (OTC) and Sulphadimethoxine (SDM) were evaluated in Nile tilapia (Oreochromis niloticus) and catfish (Clarias gariepinus). The activities of Aspartate Amino Transferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase (AP), creatinine, blood urea, were estimated. Histopathological examinations were done. Fish of groups 1 were fed a basal diet and those of 2-4 fed a medicated diet containing 1g CIP/Kg, 7.5g OTC /kg and 25mg SDM/kg ration, respectively daily for five successive days. Serum, liver, kidneys and muscles samples were collected at 0, 1st, 3rd, 7th, 14th, and 21st days of treatment. CIP, OTC and SDM concentrations were estimated by ELISA. The peak concentrations of the three drugs in serum were seen at 0 day (5th day of medication); they were (1.91±0.38ug/ml) and (1.78±0.36ug/ml) for CIP, (2.15±0.41ug/ml) and (2.02±0.31ug/ml) for OTC, (3.12±0.32ug/ml) and (2.98±0.46ug/ml) for SDM in Nile tilapia and catfish; respectively. The highest kidney concentrations of CIP were (2.1±0.65ug/g) at 1st day in Nile tilapia and (1.80±0.64ug/g) at 0 day in catfish. SDM was also concentrated in kidney at 0 day post-treatment (44.2±5.1ug/g) and (31.2±4.6ug/g) in Nile tilapia and catfish; respectively. The highest residues of OTC were estimated in liver at 0 day of treatment (6.1±1.21ug/g) and (7.4±1.35ug/g) in Nile tilapia and catfish; respectively. The lowest drug residues were in muscles throughout the entire experiment. CIP didn’t detect in muscles at 14th and 21st days post-treatment. Biochemical parameters revealed significant increase in treated groups. The histopathological examination revealed variable pathological alterations in the examined organs depending on the type of antimicrobials. It could conclude the use of antimicrobials in aquaculture should be regulated, although CIP is considered as the safest one, however its use should be limited.
Introduction
Fish consider one of the healthiest food as it is low in fat and rich in protein and omega 3 Fayet-Moore [1] & Yipel [2]. The fish farming industry is rapidly expanding in Egypt, as well as in other countries, it has been associated with recurrent bacterial infectious diseases. Farmed Nile tilapia represents more than 58.45, while catfish production is about 3.08% of the total aquaculture harvest in Egypt Gafrd [3]. Antimicrobial medications are used extensively in aquacultures for prophylactic or therapeutic purposes during microbial infections which may result in environmental pollution, development of resistant bacteria and my induce toxicity to human and animals Aly [4] & Khalil [5]. The availability of adequate data on the pharmacokinetics of antimicrobial agents in farmed fish is very important in order to minimize the environmental impacts of the drugs used in aquaculture. Since the excess amount of drugs can do harm to people, the European Union (EU) and the U.S. Food and Drug Administration (FDA) prescribed a Maximum Residue Limits (MRLs) for these drugs. The EU MRLs of CPX and SDM in fish were established at 100μg/kg Rezk [6] and 6-8μg/kg for quinolens in the edible tissues of fish Victoria [7].
Quinolones are effective antibacterial drugs widely used in human and veterinary medicine because of their potential therapeutic efficacy Plakas [8], Guo [9], Victoria [7] & Koc [10]. Ciprofloxacin is one of the most potent quinolones used to treat infections with gram negative bacteria as Escherichia coli, Pseudomonas aeruginosa, Salmonella spp., Shigella spp. and Haemophilus spp., and is also effective against some grampositive bacteria such as Staphylococcus aureus Davis [11] & Van Bambeke [12]. Oxytetracycline (OTC) is an antibacterial agent of tetracycline family that is extensively used for treatment of certain bacterial diseases in aquaculture all over the world Ambili [13]. The withdrawal time for edible tissue is differing according to the water temperature and the type of aquatic system Jeffry [14]. Because of the wide spread and long-time use of OTC, many residue studies have been recorded Rigos [15-16] & Julie [17].
Sulfonamides are the oldest antimicrobial agents and still play an important role in aquaculture treatments. Sulfamethazine (SMZ) is the most used antimicrobial drug in Veterinary field. Sulfonamides residues have been repeatedly detected in the aquatic environment Kolpin [18] & Batt [19]. Moreover sulphamethoxazole residues have been reported in shrimp by Wang [20]. Sulfamethoxazole is an effective bacteriostatic against gram positive as well as gram negative bacteria; it affects bacteria by inhibiting folic acid synthesis Baran [21]. Antimicrobial drug residues may be transferred through food-chain to human and induce antibiotic resistance. To our knowledge, however, very few data are available about residues of ciprofloxacin, oxytetracycline and SDM in farmed Nile tilapia (O. niloticus) and catfish (C. gariepinus) reared under field conditions. However, this study aimed to investigate serum concentration peaks of ciprofloxacin, oxytetracycline and SDM post-treatment and their residues in liver, kidney and muscles together with serum biochemical estimation and histopathological examinations.
Materials and Methods
Animals and diet
Three hundred and sixty fish from each of Nile tilapia (O. niloticus), and catfish (C.gariepinus) (weight, about 50 and 75g for tilapia and catfish, respectively) were supplied from Central Lab for Aquaculture Research (CLAR), Egypt and used in this experiment that was performed in triplicates, following the Universal Directive on the protection of animals used for scientific purposes. Four different basal diets (control, CIP, oxytetracycline and sulfadimethoxine) were prepared in the form of pellets to use in the study. Basal diets were prepared by grinding the corn to granules using 0.5mm mesh (Thomes-Willey Laboratory Mill Model 4). Ingredients were mixed mechanically by horizontal mixture (Hobarts model D300T) at a low speed for 30 minutes. Oil (vegetable & cod liver) was added gradually to assure the homogeneity of the ingredients, the mixing speed increased for 5 minutes during the addition of water (600ml water) until the mixture began to clump. Pellets were then prepared using a pellet machine (CPM California pellet mill Co.) with 0.5cm diameter, and pellets were left to dry in air for 24 hrs (Table 1).
Fish with a history of no previous medication, were divided into 4 groups (each of three replicates, 30 fish each) and held in floating cages placed in fish farm ponds and group 1 fed a basal diet while groups 2-4 fed a medicated diet containing 1g CIP, 7.5g OTC and 25mg SDM/kg ration; respectively on a daily bases for five successive days. The temperature was recorded every 12h and adjusted to (26-30°C). The treatment was carried out once daily at 9 a.m. for 5 successive days at a rate of 1 .0% biomass using automatic feeders. Salinity, pH and total hardness were adjusted to, 3±1.1%, 8.21±0.21 and 38.9±1.9mg/L; respectively.
Sampling of the fish
The first sampling day was the 5th day of medication (0 day post treatment), and on the 1st, 3rd, 7th, 14th, and 21st days after the end of treatment with the antimicrobials. At each time of sampling, 15 fish from each group (5fish/replicate) were netted. Fish were anesthetized by immersion in water containing 0.1ppm MS-222 and blood samples were collected. Serum samples and muscle, liver and kidney specimens were collected from all groups. Muscle samples were taken from the dorso-lateral body area just posterior to the operculum. Each specimen was placed in a polyethylene bag and stored at -80°C until they were analyzed. CIP, OTC and SDM concentrations were estimated by ELISA.
Biochemical Studies
The activities of Asparate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase (AP), creatinine and urea, were estimated using commercial diagnostic Kits (Human Diagnostics, Germany). Methods were carried out according to the company directions.
Histopathological examinations
Tissues specimens from the muscles, liver and kidneys were collected at 5th day post-treatment and processed routinely according to Drury and Wallington (1980). Sections were stained with hematoxylin and eosin (H&E) and examined by light microscope.
Statistical analysis:
Statistical analysis was performed using the one way analysis of variance (ANOVA) followed by Duncan’s multiple range test to determine the differences among the six fish groups (mean at significance level of P<0.05). All analyses were run on the computer using SAS program Chris Hemedinger [2].
Results
Drug residues
Mean concentrations of the drugs (mean ± SE) vs. time in the serum, liver, kidney and musculature were recorded in (Table 1-3). The peak concentrations of the three drugs in serum were at 0 day. The lowest drug residues were seen in the muscles throughout the entire experiment.
Ciprofloxacine: Results obtained after oral dose of 1 g CIP/kg ration for 5 successive days were shown in (Table 2). The highest recorded concentrations of CIP in sera of Nile tilapia and Catfish were (1.91±0.38ug/ml) and (1.78±0.36ug/ml), respectively at 0 day. CIP concentrations were identified all over the experiment in kidneys with the highest concentrations (2.1±0.65ug/g) at 1st day in Nile tilapia and (1.80±0.64ug/g) at 0 day in kidneys in catfish. CIP neither detected in muscles of Nile tilapia nor of Catfish at 14th and 21st days post-treatment while, were not detect in livers of both kinds of fish at 21st days post-treatment.
Oxytetracycline: (Table 3) shows the serum, liver, kidney and muscle concentrations of OTC versus time in Tilapia and Catfish after oral administration of 75mg OTC/kg ration for 5 successive days. Peaks of OTC in serum were (2.15±0.41ug/ ml) and (2.02±0.31ug/ml) at 0 day in Nile tilapia and Catfish; respectively while, it was not detect in sera of both fish species after 14th and 21st days but detected only in one Catfish (0.03μg / ml) at 7th day post treatment. The highest tissue residues of OTC were (6.1±1.21ug/g) and (7.4±1.35ug/g) in liver of Nile tilapia and Catfish; respectively at 0 day of the treatment. In Nile tilapia and Catfish the OCT concentrations in kidneys were 0.08±0.04 and 0.05±0.02 (μg /g); respectively at 21st day post treatment. The lowest drug residues were in muscles throughout the entire experiment. OCT concentrations were detected in muscles of Nile tilapia and Catfish at (0.10±0.03ug/g) and (0.14±0.02ug/g); respectively after 21 days post treatment
Sulphadimethoxine: (Table 4) showed the mean concentrations of SDM in Nile tilapia and Catfish sera and tissues versus time profile after oral administration of 25mg SDM/kg ration for 5 successive days. The highest serum concentrations of SDM were (3.12±0.32ug/ml) and (2.98±0.46ug/ml) at 0 day in Nile tilapia and Catfish; respectively while it was detected in only one Tilapia fish (0.04μg /ml) at 7th day of treatment and not thereafter was detected. SDM was detected in kidneys of both Tilapia and catfish all over the experiment. SDM highest concentrations in kidney were at 0 day post-treatment (44.2±5.1ug/g) and (31.2±4.6ug/g) in Nile tilapia and Catfish; respectively. At 21st day of treatment; SDM was not detected in muscles and liver of Catfish but detected only in one Tilapia fish (0.11ug/g and 0.03ug/g in liver and muscles; respectively).
Biochemical results
(Figure 1,2) represented the biochemical results at 5th day of oral administration of CIP, OTC and SDM in both Nile tilapia and Catfish. ALT was significantly increased in both fish species after 5 days of oral administration of the three drugs compared with control. In Tilapia fish AST was significantly increased after administration of the three tested drugs while, in Catfish AST was significantly increased after administration of OTC and SDM in comparison with control. Creatinine was significantly increased in Nile tilapia with all three drugs but in Catfish it was significantly increased with OTC and SDM whereas not increased with CIP. Urea was significantly increased in Tilapia fish after administration of all drugs except OTC while, in Catfish urea was significantly increased in both OTC and SDM but not significantly changed in case of CIP compared with control.
Histopathological results
The oral administration of 1g CIP/kg ration for 5 successive days in Nile tilapia and Catfish at 5th days post-treatment, revealed minimal histopatholoigical alterations in comparison with the other treated groups. The musculature exhibited hyaline degeneration in few muscle bundles (Figure 3), the liver displayed nuclear pyknosis of some hepatocytes with mild parenchymal edema (Figure 4) while the kidneys showed proliferation of melanomachrophage cells and mild tubular nephrosis in the renal epithelium (Figure 5). The oral administration of 75mg OTC/kg ration, for 5 successive days in Tilapia and Catfish at 5th day posttreatment, revealed edema and focal hyaline degeneration in the musculature (Figure 6). Focal proliferation of melanomoacrophage cells was observed in the liver and kidney parenchyma. Wide spread vacuolar degeneration in the hepatocytes (Figure 7) and tubular nephroses in the renal tubular epithelium (Figure 8) were evident.
The oral administration of 25mg SDM/kg ration, for 5 successive days in both Nile tilapia and Catfish at 5th days posttreatment, revealed edema and hyaline degeneration as well as focal Zenker’s necrosis in the musculature with focal of mononuclear leukocytic infiltration (Figure 9). The liver exhibited wide spread vacuolar degeneration as well as coagulative necrosis in the hepatocytes with some mononuclear cells infiltration and melanomacrophages (Figure 10). The kidney showed tubular nephrosis mainly vacuolar degeneration with few cells exhibited coagulative necrosis, hyaline casts and few mononuclear cells infiltrations were evident (Figure 11).
Discussion:
Using of antimicrobial drugs in aquaculture production is one of the main sources of environmental pollution Pruden [23]; Rico & Van den Brink [24]. During the past years there was increase in the occurrence of antibiotic resistant bacteria and this is of critical implications on public health Gouvêa [25] & Rezk [6]. Quesada [26] & Guidi [27] mentioned that tetracycline, oxytetracycline (tetracyclines), enrofloxacin (quinolones), and sulfadimethoxine (sulfonamide) are most commonly used antibiotics in aquaculture worldwide and the presence of their residues in food could resulted in health hazards and toxic effects. Therefore, understanding the depletion of drugs from different tissues of fish is of extreme importance and the drug residues must be assessed in order to determine the time needed before the antimicrobials disappear from the tissues and to judge when the treated fish can be safely consumed. There are limited data about the occurrence of drugresidues in intensive culture of freshwater fishes in Egypt, hence the goal of this study was to estimate tissue distribution and residue depletion after oral administration of CIP, OTC and SDM in Nile tilapia (O. niloticus) and catfish (C. gariepinus).
The elimination and residues of antimicrobials depend upon dose, duration, fish species, and aquaculture conditions He [28]. Nile tilapia and catfish are kinds of tropical fish and the appropriate temperature for survival is ranging between 24– 32°C. The water temperature in this study was 26-30°C and the research was conducted on healthy fish in conditions those are quite close to actual aquaculture. In this study the withdrawal time of CIP from serum in both O. niloticus and C. gariepinus was almost 7days. Guo [9] concluded that CIP in eels eliminated from plasma for about 298h, after oral gavage of a single dose (10μg / kg). Wu [30] reported that, elimination half life of enrofloxacine and its metabolite ciprofloxacin were 15.61, 16.83, and 17.19h in muscle, liver, and plasma of Tilapia; respectively. Ciprofloxacin concentration was 0.3 and 0.1μg/g in liver and muscle of Chinese mitten-handed crab after single intramuscular injection of 5.0mg enrofloxacin/kg body weight Guanghong [31]. The maximum enrofloxacin concentrations in the muscle, liver and plasma of O. niloticus were 3.61μg/g, 5.96μg/g and 1.25μg/ml; respectively after oral dose of enrofloxacine (50mg/kg) for 7 days and the predicted withdrawal time was 22 days Weihai [32]. Withdrawal
time of CIP from muscle and liver under our experimental conditions was 14 days in both O. niloticus and C. gariepinus. Enrofloxacin metabolized into ciprofloxacin therefore, extended withdrawal time for enrofloxacin is recommended. Renal CIP concentrations in both O. niloticus and C. gariepinus were 0.12μg/g and 0.10μg/g; respectively at 21 days post-treatment. The main target organ for CIP metabolism is kidney Ole [33]. Our results showed that, serum OTC concentrations at 0 day posttreatment (5th day of medication) in Nile tilapia and catfish were 2.15 and 2.02μg/mL; respectively. Food and Drug Administration (FDA) regulations specify OTC treatment in finfish culture at 55 to 83mg/kg fish per day for 10 days with a 21-day withdrawal prior introducing for food. After 21 days, OTC concentrations must be below the tolerance of 2ppm (μg/g). The mean peak concentrations of OTC at 0 day post-treatment in fish muscle of O. niloticus and C. gariepinus were 0.94 and 0.99μg/g; respectively. Comparable to other studies carried out in farmed fish; Bjorklund & Bylund [34] found peak OTC concentrations of 0.6-1.5ug/g in farmed rainbow trout and salmon. Our study showed that, OCT concentration in muscle was 0.10μg/g and 0.14μg/g in O. niloticus and C. gariepinus at 21 day post-treatment. Rigos [16] recorded plasma and muscle concentrations of OCT were 0.9±0.2μg/ml and 3.0 ±1.1 μg/g in seabream 150 hours post single intravascular injection (40mg/kg) while, at 24h post-oral dosing (75mg/kg) muscle and liver concentrations of OCT were 0.008 and 6.2±1.8 (μg/g); respectively. Julie [17] observed that OCT concentrations in muscles of adult rainbow trout were below 2ug/g by 21 days after withdrawal of OTC medicated feed for 10 days. Bjorklund & Bylund [34] reported OCT concentration in muscle of rainbow trout (Salmo gairdneri ) to be below 1ug/g by 14 days after drug withdrawal. Josè [35] concluded OTC concentrations in sea bream muscle were lower than in all the other tissues and declined under 0.1ug/g 20 days after treatment ceased. Meanwhile, Rigos [17] concluded poor intestinal absorption of OCT and that oral administration was unsuccessful in sharp snout sea bream. Reda [36] found that, the OTC residues in O. niloticus muscles were 0.05ug/g after a withdrawal period of 15 days when supplemented in diet at 100mg/kg diet for 12 weeks, this level was lower than the MRLs of OTC (0.1ug/g) that established by commission regulations, EU [37]. The differences between these species are likely the result of physiological differences between species and/ or differences in experimental design. Hepatic accumulation of OCT in our work was observed in both O. niloticus & C.s gariepinus (0.51 and 0.98μg/g) 21 day post-treatment, respectively. Hepatic metabolism is the major route for OCT metabolism in different fish species. Rigos [17] and Bjorklund & Bylund [34] recorded OTC hepatic accumulation. Ole [38] recorded the highest average concentrations of SDM in plasma and muscles of Atlantic salmon (14.30μg/ml and 17.72μg/g, respectively) after oral administration in feed for 5 consecutive days as well as the withdrawal time was 288, 300 and 350 hrs in muscle, liver and kidney; respectively. The elimination half-life of SDM from blood of rainbow trout was 24.5 hours after a single oral administration (200mg/kg), at a water temperature of 15°C Kauzauki [39]. Our work showed that, the highest average concentration of SDM in liver, kidney and muscle were 8.95, 44.2 and 2.15μg/g; respectively in Nile tilapia at 0 day post-treatment. The corresponding values in catfish were 6.14, 31.2 and 2.02μg/g; respectively. SDM was not detectible at the 21th day post-treatment in muscle of C. gariepinus and detected only in one O. niloticus.
Conclusion
The antimicrobial drugs based on dose and type may negatively impact the liver and kidney functions with significant changes in enzymatic parameters and histopathological picture [48-55]. Also, the three tested medications had residues in the liver, kidney and muscles of Nile tilapia and catfish, the lowest drug residues were in muscles. CIP is considered as the safest one with the least residues. For the control of fish bacterial diseases, preventive measures should be applied and during urgent need, the selection of correct antimicrobial agent is very important through frequent antimicrobial sensitivity testing. An antimicrobial with minimal residue limit should be selected to protect animal and human health from potential hazards caused by contaminated fish. However, further studies are needed to estimate the toxicity of therapies in the aquatic creatures and environment.
Ethical approval
All the animals were maintained in accordance with the National and International Institutional Guidelines for the Care and Use of Animals for Scientific purposes.
Competing interest
The authors declare that they have no significant competing financial, professional or personal interests that might have influenced the performance or presentation of the work described in this manuscript.
References
- Fayet-Moore F, Baghurst K, Meyer BJ (2015) Four models including fish, seafood, red meat and enriched foods to achieve Australian dietary recommendations for the n-3 LCPUFA for all life-stages. Nutrients 7(10): 8602-8614.
- Yipel M, Kürekci C, Tekeli IO, Metli M, Sakin F (2017) Determination of selected antibiotics in farmed fish species using LC‐MS/MS. Aquaculture Res 48(7): 3829-3836.
- General Authority for Fish Resources Development (GAFRD) (2014). 2009 Statistics Yearbook. 24th Edition, Ministry of Agriculture Publications.
- Aly SM (2103) A Review of Fish Diseases in the Egyptian Aquaculture Sector. Working Report www.livestockfish.cgiar.org., 1-25.
- Khalil WF, Shaheen HM, Abdou RH (2016) Ceftiofur pharmacokinetics in Nile tilapia Oreochromis niloticus after intracardiac and intramuscular administrations. Dis Aquat Org 121(1): 29-35.
- Rezk MR, Riad SM, Khattab FI, Marzouk HM (2015) Multi-residues determination of antimicrobials in fish tissues by HPLC–ESI-MS/MS. method. J Chromatogr B Analyt Technol Biomed Life Sci 978-979: 103-110.
- Samanidou V, Evaggelopoulou E, Trötzmüller M, Guo X, Lankmayr E (2008) Multi-residue determination of seven quinolones antibiotics in gilthead seabream using liquid chromatography-tandem mass spectrometry. J Chromatogr A 1203(2): 115-123.
- Plakas SM, El Said KR, Musser SM (2000) Pharmacokinetics, tissue distribution, and metabolism of flumequine in channel catfish (Ictalurus punctatus). Aquaculture 187(1-2): 1-14.
- Guo L, Xie Z, Lin X, Wu X, Qiu B, et al. (2005) Pharmacokinetics of ciprofloxacin in eels by high-performance liquid chromatography with fluorescence detection. Analytical Biochemistry 341(2): 275-279.
- Koc F, Uney K, Atamanalp M, Tumer I, Kaban G (2009) Pharmacokinetic disposition of enrofloxacin in brown trout (Salmo trutta fario) after oral and intravenous administrations. Aquaculture 295(1-2): 142-144.
- Davis R, Markham A, Balfour J (1996) Ciprofloxacin. Drugs 51(6): 1019-1074.
- Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM (2005) Quinolones in 2005.
- Ambili TR, Saravanan M, Ramesh M (2013) Toxicological Effects of the Antibiotic Oxytetracycline to an Indian Major Carp Labeo rohita. Arch Environ Contam Toxicol 64: 494-503.
- Jeffry Bernardya A, Chue Vuea, Mark Gaikowskia P, Guy Stehlya R, William Gingericha H, et al. (2003): Residue depletion of oxytetracycline from fillet tissues of northern pike and walleye. Aquaculture 221(1-4): 657-665.
- Rigos G, Nengas I, Alexis M, Tyrpenou AE, Troisi G (2003) Issue distribution and residue depletion of oxolinic acid in gilthead sea bream (Sparus aurata) and sharpsnout sea bream (Diplodus puntazzo) following multiple in-feed dosing. Aquaculture 224(1-4): 245-256.
- Rigos G, Tyrpenou, Nengas I, Alexis AEM, Athanassopoulou F, et al. (2004) Poor bioavailability of oxytetracycline in sharpsnout sea bream Diplodus puntazzo. Aquaculture 235(1-4): 489-497.
- Julie Bebak-Williams, Graham Bullock, Mary Carson C (2002) Oxytetracycline residues in a freshwater Recirculating system. Aquaculture 205(3-4): 221-230.
- Kolpin D, Furlong E, Meyer M, Thurman E, Zaugg S, et al. (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36(6): 1202-1211.
- Batt A, Snow D, Aga D (2006) Occurrence of sulfonamide antimicrobials in private water wells in Washington County, Idaho, USA. Chemosphere 64(11): 1963-1971
- Wang Weifena, Lin Honga, Xue C, Khalid J (2004) Elimination of chloramphenicol, sulphamethoxazole and oxytetracycline in shrimp, Penaeus chinensis following medicated-feed treatment. Environment International 30(3): 367-373.
- Baran W, Adamek E, Ziemiańska J, Sobczak A (2011) Effects of the presence of sulfonamides in the environment and their influence on human health. J Hazard Mater 196: 1-15.
- Chris Hemedinger (2005): Boost Your Programming Productivity with SAS Enterprise Guide, Proceedings of the Thirtieth Annual SAS Users Group International Conference.
- Pruden A, Larsson DG, Amezquita A, Collignon P, Brandt KK, et al. (2013) Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ Health Perspect 121(8): 878-885.
- Rico A, Van den Brink PJ (2014) Probabilistic risk assessment of veterinary medicines applied to four major aquaculture species produced in Asia. Science of the Total Environment 468: 630-641.
- Gouvêa R, Dos Santos FF, De Aquino MHC, Pereira VL de A (2015) Fluoroquinolones in industrial poultry production, bacterial resistance and food residues:a review. Rev Bras Cienc Avic 17(1): 1-10.
- Quesada SP, Paschoal JAR, Reyes FAG (2013) Considerations on the Aquaculture Development and on the Use of Veterinary Drugs: Special Issue for Fluoroquinolones- a review. Journal of Food Science 78(9): 1321-1333
- Guidi LR, Santos FA, Ribeiro ACSR, Fernandes C, Silva LHM, et al. (2018) Quinolones and tetracyclines in aquaculture fish by a simple and rapid LC-MS/MS method. Food Chemistry 245(15): 1232-1238.
- Baran W, Adamek E, Ziemiańska J, Sobczak A (2011) Effects of the presence of sulfonamides in the environment and their influence on human health. Hazardous Materials 196: 1-15.
- He X, Wang Z, Nie X, Yang Y, Pan D, et al. (2012): Residues of fluoroquinolones in marine aquaculture environment of the Pearl River Delta, South China. Environ Geochem Health 34(3): 323-335.
- Wu WH, Lin LM, Zhu XB, Wang XT, Huang XP, et al. (2004) Residues of enrofloxacin and its metabolite in Jifu Tilapia and Penaeus chinensis. Fish Sci 23: 5-8.
- Guanghong Wu, Yong Meng, Xiaohua Zhu, Cheng Huang (2006) Pharmacokinetics and tissue distribution of enroXoxacin and its metabolite ciproXoxacin in the Chinese mitten-handed crab Eriocheir sinensis. Analytical Biochemistry 358: 25-30.
- Weihai Xu, Xiaobin Zhu, Xinting Wang, Liping Deng, Gan Zhan (2006) Residues of enrofloxacin, furazolidone and their metabolites in Nile tilapia (Oreochromis niloticus). Aquaculture 254: 1-8.
- Ole Bent Samuelsen (2006) Pharmacokinetics of quinolones in fish: A review. Aquaculture 255: 55-75.
- Bjorklund H, Bylund G (1990) Temperature-related absorption and excretion of oxytetracycline in rainbow trout (Salmo gairdneri R.). Aquaculture 84: 363-372.
- Josè Malvisi, Giorgia della Rocca, Paola Anfossi, Giorgio Giorgetti (1996) Tissue distribution and residue depletion of oxytetracycline in sea bream (Sparus aurata) and sea bass ( Dicentrarchus Zabmx) after oral administration . Aquaculture I47: 159-168.
- Reda RM, Ibrahim RE, El-Nobi GA, El-Bouhy ZM (2013) Effect of oxytetracycline and florfenicol as growth promoters on the health status of cultured Oreochromis niloticus. Egyptian Journal of Aquatic Research 39(4): 241-248.
- Commission regulation EU (2010) On pharmacologically active substances and their classification regarding maximum residue limits in food stuffs of animal origin. Official journal of the European Union.
- Ole Bent Samuelsen, Lisa Purse, Peter Smith, Arne Ervik (1997) Multiple-dose pharmacokinetic study of Romet”’ in Atlantic salmon (Sdmo sahr) and in vitro antibacterial activity against Aeromonas salmonicida. Aquaculture 152: 13-24.
- Kauzauki Uno, Takahiko Oiho, Ruje unibo (1993) Pharmacokinetics of sulphamonomethoxine and SDM following oral administration to cultured rainbow trout (Oncorhynchus mykiss). Aquaculture 115(3-4): 209-219.
- Kori-Siakpere O, Bemigho IR, Gbemi OM (2010) Varriations in alanine aminotransferase and aspartate aminotransferase activities in african catfish: Clarias gariepinus (Burchell, 1822) at different sublethal concentrations of potassium permanganate. Sci Res Essays 5(12): 1501-1505.
- Lavanya S, Ramesh M, Kavitha C, Malarvizhi A (2011) Hematological, biochemical and ionoregulatory responses of Indian major carp Catla catla during chronic sublethal exposure to inorganic arsenic. Chemosphere 82(7): 977-985.
- Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, et al. (2004) Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharmacol 39(2): 158-183.
- Pacheco M, Santos MA (2002) Biotransformation, ecotoxic and histopathological effects of environmental contaminants in European eel, Anguilla anguilla (L). Ecotoxicol Environ Saf 53(3): 331-347.
- Pyriyadharshiri KM, Vanithakumari GV (2013) Ciprofloxacin-induced body weight and serum biochemical changes in rats and antioxidant vitamin A, C and E as rescue agents. Int J Eng Sci 4(5): 1211-1213.
- Osonwa UE, Ugochukwu JI, Onyegbule FA, Esimone CO (2016) Pharmacokinetics, hematological and biochemical effects of ciprofloxacin hydrochloride-sodium cholate complex. Int J Pharm Pharm Sci 8(10): 96-101
- Soler F, Reja A, García-Rubio L, Míguez MDP, Roncero V (1996) Anatomo-pathological effect of oxytetracycline in tench (Tinca tinca). Toxicology Letters 88: 104.
- Gaikowski MP, Wolf JC, Schleis SM, Tuomari D, Endris RG (2012) Safety of Florfenicol Administered in Feed to Tilapia (Oreochromis sp.). Toxicol. Pathol. 41(4): 639-652.
- Abedini S, Namdari R, Law FCP (1998) Comparative pharmacokinetics and bioavailability of oxytetracycline in rainbow trout and Chinook salmon. Aquaculture 162: 23-32.
- Lavanya S, Ramesh M, Kavitha C, Malarvizhi A (2011) Hematological, biochemical and ionoregulatory responses of Indian major carp Catla catla during chronic sublethal exposure to inorganic arsenic. Chemosphere 82(7): 977-985.
- Drury RAB, Wallington EA (1980) Preparation and fixation of tissues. In: Drury RAB, Wallington EA, editors. Carleton's Histological Technique. 5. Oxford: Oxford University Press: pp.41-54.
- Sabrina M, Prevarin A, Tubaro F (2011) Levels of creatine, organic contaminants and heavy metals in creatine dietary supplements. Food Chemistry 126: 1232-1238
- Lewbart G, Vaden S, Deen J, Manaugh C, Whitt D, et al. (1997) Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscolar, oral and bath administration. J Vet Pharmacol Ther 20(2): 124-128.
- Society of Clinical Microbiology and Infectious Diseases 11(4): 256-280.
- Wojciech B, Ewa Adamek, Justyna Z, Andrzej S (2011) Effects of the presence of sulfonamides in the environment and their influence on human health. Journal of Hazardous Materials 196: 1-15.
- Clinical Microbiology and Infection : The Official Publication of the European.